Abstract

BackgroundCo-existence of periodontitis and rheumatoid arthritis (RA) has been reported. These diseases have similarities in aetiology, pathogenesis and risk factors. Porphyromonas gingivalis (PG) is a periodontal pathogen that has the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
THU0082 Anti-P. Gingivalis Antibody is Correlated with Severity of Periodontitis (PD) but not with Rheumatoid Arthritis (RA) Disease Activity in RA
J.-H Kim ... H J Oh
Annals of the Rheumatic Diseases | VOL. 72
J.-H Kim, et. al.J.-H Kim ... H J Oh
01 Jun 2013
Rheumatoid arthritis and heart disease: the chicken and the egg?
Cynthia S Crowson
Journal of Internal Medicine | VOL. 268
Cynthia S CrowsonCynthia S Crowson
05 Nov 2010
THU0058 Periodontal disease is associated with rheumatoid arthritis (RA) but its severity is not correlated with RA disease activity
Y.-M Lee ... E.B Lee
Annals of the Rheumatic Diseases | VOL. 71
Y.-M Lee, et. al.Y.-M Lee ... E.B Lee
01 Jun 2013
Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.
Eun Bong Lee ... Yong-Moo Lee
BMC musculoskeletal disorders | VOL. 16
Eun Bong Lee, et. al.Eun Bong Lee ... Yong-Moo Lee
12 Aug 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers